Social Media: Ignorance Not Bliss For Pharma, DIA Panelists Say

Drugmakers must start monitoring adverse event data and product discussions on the Internet or run the risk of facing legal scrutiny, marketing specialists said at a Feb. 25 Drug Information Association conference in New York City